ArticleFrontiers in immunology2023

Avidity engineering of human heavy-chain-only antibodies mitigates neutralization resistance of SARS-CoV-2 variants.

Wenjuan Du et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.